Zhittya Regenerative Medicine Inc. (Zhittya means “life” in Ukrainian) is advancing a group of drugs which trigger the human body’s natural regeneration process. Zhittya’s regenerative drugs act by specifically stimulating the growth of new blood vessels (a biological process termed “angiogenesis”) in tissues or organs that have perfusion defects. Lack of blood perfusion to an organ or tissue is the single biggest cause of death in the world. In fact, according to the Angiogenesis Foundation in Cambridge, MA, over 70 human diseases have been linked to a lack of blood perfusion. As detailed in the Pipeline section of our website, Zhittya has clinical development programs in 8 separate medical conditions, most of which are believed to be caused by a lack of blood perfusion.